Literature DB >> 555689

Nature of the hemopoietic stem cell compartment and its proliferative potential.

L E Botnick, E C Hannon, S Hellman.   

Abstract

The nature of the hemopoietic stem cell compartment has been the subject of much controversy. Data are presented to support the concept of a 'continuum' model of the stem cell compartment. The important characteristics of this model are that within the continuum there are cells with varying proliferative capacities. As cells move through the compartment, their proliferative capacity becomes more limited, their likelihood to be in cycle increases, and their commitment to a specific differentiated pathway increases. Experiments with busulfan, cyclophosphamide, 5-flurouracil, and BCNU demonstrate defects in proliferative potential of the surviving CFU-S population. These defects persist throughout the life of the animal without any evidence of recovery. The clinical implications of late stem cell failure may be important as a consideration in the use of cytotoxic agents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 555689

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  10 in total

Review 1.  Mechanistic models for myelosuppression.

Authors:  Lena E Friberg; Mats O Karlsson
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

2.  Partitioning of bone marrow into stem cell regulatory domains.

Authors:  M A Maloney; R A Lamela; M J Banda; H M Patt
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

3.  Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures.

Authors:  P Mauch; J S Greenberger; L Botnick; E Hannon; S Hellman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

4.  Tolerance of hemopoiesis for repeated cytotoxic drug therapy.

Authors:  H P Lohrmann
Journal:  Blut       Date:  1979-10

5.  Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.

Authors:  Santhi Gorantla; Hannah Sneller; Lisa Walters; John G Sharp; Samuel J Pirruccello; John T West; Charles Wood; Stephen Dewhurst; Howard E Gendelman; Larisa Poluektova
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.

Authors:  T Nakahata; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients.

Authors:  Brian C Beard; Reeteka Sud; Kirsten A Keyser; Christina Ironside; Tobias Neff; Sabine Gerull; Grant D Trobridge; Hans-Peter Kiem
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

8.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure.

Authors:  D E Harrison; C M Astle
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  Assessment of myelotoxicity caused by environmental chemicals.

Authors:  G A Boorman; M I Luster; J H Dean; M L Campbell
Journal:  Environ Health Perspect       Date:  1982-02       Impact factor: 9.031

10.  Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.

Authors:  M A Cornbleet; T J McElwain; P J Kumar; J Filshie; P Selby; R L Carter; D W Hedley; M L Clark; J L Millar
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.